Feasibility and benefits of continuous glucose monitoring for type 1 diabetes in Rwanda: A real‐world 12‐month continuation phase
CGM-related improvements in HbA1c and TIR among Rwandans living with T1D were maintained for at least 24 months. CGM should be considered as an important tool to improve diabetes self-management in LMICs.
Authors
- Jean Claude Habineza (ORCID: https://orcid.org/0000-0001-6931-556X)
- Simon Pierre Niyonsenga
- Jason Baker (ORCID: https://orcid.org/0000-0002-0837-1143)
- Sandhya Narayanan (ORCID: https://orcid.org/0009-0003-1437-9912)
- John B. Welsh
- Giacomo Cappon
Institutions
- University of Padua (IT)
- University of Rwanda (RW)
- Rwanda Diabetes Association (RW)
- Dexcom (United States) (US)
- Empowerment Program (US)
- Rwanda Biomedical Center (RW)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2026-03-09
- DOI
- https://doi.org/10.1111/dme.70284
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00